FDA — authorised 14 August 1987
- Application: NDA019763
- Marketing authorisation holder: BAXTER HLTHCARE
- Local brand name: IFEX
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Ifex in United States
FDA authorised Ifex on 14 August 1987
Marketing authorisations
FDA — authorised 30 December 1988
- Marketing authorisation holder: BAXTER HLTHCARE
- Status: approved
Ifex in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in United States
Frequently asked questions
Is Ifex approved in United States?
Yes. FDA authorised it on 14 August 1987; FDA authorised it on 30 December 1988.
Who is the marketing authorisation holder for Ifex in United States?
BAXTER HLTHCARE holds the US marketing authorisation.